Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
1.4 CHEMICAL SCIENCES, 3. MEDICAL AND HEALTH SCIENCES, 3.4 HEALTH BIOTECHNOLOGY
This paper presents an Irish research study currently being undertaken by the Pharmaceutical Regulatory Science Team at the Dublin Institute of Technology (DIT) into the impact of new pharmaceutical regulatory guidance on the development and manufacture of medicinal drug products.
It launches a Pharmaceutical Industry Benchmarking Questionnaire designed to assess the impact and level of implementation of the ICH Tripartite Quality Guidance Q8, Q9 and Q10.
Calnan, N. (2011). Benchmarking the Pharmaceutical Industry: A briefing on an Irish Research Study. International Society of Pharmaceutical Engineers (ISPE): Quality Risk Management conference, Frankfurt, Germany. doi:10.21427/ksaf-yg85
International Society of Pharmaceutical Engineers (ISPE) Frankfurt April 2011: Quality Risk Management conference